Literature DB >> 8417533

Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.

B L Ohning1, D A Fyfe, P A Riedel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8417533     DOI： 10.1016/0002-8703(93)90089-r

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  Cardiac effects of short course dexamethasone in preterm infants.

Authors:  R Skelton; A B Gill; J M Parsons
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

2.  Identifying the aetiology of left ventricular hypertrophy in an athlete: importance of lifestyle modification.

Authors:  Miriam Jane Ball; Niall Keenan; Mary Lynch; Sanjay Prasad; Diana A Gorog
Journal:  BMJ Case Rep       Date:  2009-12-01

3.  Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription.

Authors:  S Muangmingsuk; P Ingram; M P Gupta; R A Arcilla; M Gupta
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.